Quest Magazine

MDA Scientific Conference Update: March 12 Afternoon Sessions

MDA Scientific Conference Update: March 12 A.M. Sessions

MDA 2015 Scientific Conference to Emphasize Urgent Need for Discovery and Treatment

Kroger-Atlanta Division Supports MDA Shamrock Tradition to Help Families Fighting Muscle Disease

MDA Adds Muscle Disease and ALS Leaders to Research Team

DMD: New Strategy Aims to Change Dystrophin DNA

MDA research grantee Charles Gersbach, assistant professor of biomedical engineering at Duke University, and colleagues, recently announced an advance in gene modification that could turn out to be a game-changer for boys and young men with Duchenne muscular dystrophy (DMD). The team's results were published Feb.

Statement: New MDA-Funded Genetic Therapy Technique Targets DMD

CHICAGO, Feb. 27, 2015 – Muscular Dystrophy Association research grantee Charles Gersbach, Assistant Professor of Biomedical Engineering at Duke University, recently announced a potentially game-changing advance in gene modification for boys and young men with Duchenne muscular dystrophy (DMD). The results were published Feb.

MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease

Anything But Rare

I recently stumbled upon a definition of the word “rare” that profoundly unnerved me: “rare — not found in large numbers and consequently not of interest or value.”

ReveraGen BioPharma Announces Start of Phase 1 Clinical Trial of VBP15 Dissociative Steroid Drug